SEC Form 4 · accession 0001179110-16-031371
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Enyedy
Officer — Chief Executive Officer · Director
Period of report
Nov 8, 2016
Accepted (ET)
Nov 9, 2016 · 1:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 8, 2016 | P | 25,000 | $1.8295 | A | 100,100 | D |
Table II — derivative securities
No Table II lines on this filing.